Apidra Solostar 3 Ml Solution 5 Pen

A rapid-acting insulin pen pre-filled with insulin glulisine, designed for mealtime blood sugar control in adults and children with diabetes.

Indications:
- Used to improve glycemic control in both Type 1 and Type 2 diabetes.
- Suitable for adults, adolescents, and children aged 6 years and older.
- Administered around mealtimes—within 15 minutes before or up to 20 minutes after starting a meal.

Main Active Ingredient:
- Insulin glulisine.

Precautions:
- Do not use during episodes of hypoglycemia.
- Inspect the solution visually; use only if clear and free from particles.
- Avoid sharing pens, needles, or syringes with others.
- Rotate injection sites (abdomen, thigh, upper arm) to minimize lipodystrophy.
- Store unused pens refrigerated (2–8 °C); in-use pens may be kept at room temperature less for up to 28 days.

Side Effects:
- Hypoglycemia (low blood sugar).
- Local reactions: redness, itching, or swelling at injection site; potential skin thickening or lipodystrophy.
- Rare serious reactions: severe allergic responses (e.g., hives, difficulty breathing).


Drug–Drug Interactions:
- Other glucose-lowering agents (e.g., SGLT2 inhibitors, sulfonylureas).
- Alcohol.

- Attach a new needle before each injection.
- Prime the pen (e.g., dial 2 units and press to release insulin).
- Dial the prescribed dose in 1-unit increments.
- Inject subcutaneously in the abdomen, thigh, or upper arm.
- Hold the pen in place for 10 seconds after injection to ensure full delivery.
- Dispose of the pen safely after use, and store per storage guidelines.

• Blood sugar control
• Glucose level reduction
• Diabetes

Insulin glulisine, metacresol, sodium chloride, trometamol, polysorbate 20, hydrochloric acid (to adjust pH), sodium hydroxide (to adjust pH), water for injections